In a previous pilot protocol on breast cancer [19], the tumoral transcriptomic analysis showed that the presence of I2 alone or with conventional chemotherapy induces the reactivation of antitumor immune responses, increasing the number of CD8+, dendritic and B-lineage cells. The gene discussed is CD8A; the disease is breast cancer.